http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104262445-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J17-005 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7032 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2014-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104262445-B |
| titleOfInvention | Camellia nitidissima saponin A, and preparation method and antitumor application thereof |
| abstract | The invention relates to a new Camellia nitidissima saponin A compound separated from Camellia nitidissima and a preparation method thereof, and application of the compound in tumor resistance. The dammarane saponin new compound is separated from Camellia nitidissima. The new compound is named (3beta,6alpha,12beta)-3,6,12-trihydroxydammaryl-24-alkenyl-20-methyl-2-O-beta-D-glucopyranosyl-(2-＞1)-O-beta-D-glucopyranosyl-(2-＞1)-O-alpha-L-pyranylrhamnosido[(3beta,6alpha,12beta)-3,6,12-trihydroxydammar-24-en-20-yl-2-O-beta-D-glucopyranosyl-(2-＞1)-O-beta-D-glucopyranosyl-(2-＞1)-O-alpha-L-Rhamnopyranoside]. A CCk-8 process is utilized to carry out antitumor activity detection on the new compound; and the experimental result indicates that the compound has the activities for inhibiting human lung cancer BeL-7402 cells, SMMC-7721 and the like from growth. |
| priorityDate | 2014-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 62.